Mauna Kea Technologies

Develops technology for optical biopsies.

Launch date

2000

Employees

Market cap

Enterprise valuation

€60m (Public information from Sep 2024)

Company register number 431268028

Paris Île-de-France (HQ)

https://www.maunakeatech.com/en/

https://twitter.com/maunakeatech https://www.facebook.com/maunakeatech https://www.linkedin.com/company/mauna-kea-technologies/https://apps.apple.com/app/id466397635 https://play.google.com/store/apps/details?id=com.hcnx.cellvizio

Revenues, earnings & profits over time

EUR	2020	2021	2022	2023	2024	2025	2026
Revenues	7.0m	8.0m	7.0m	10.5m	7.1m	8.2m	9.4m
% growth	-	14 %	(13 %)	50 %	(32 %)	15 %	15 %
EBITDA	(11.0m)	(9.0m)	(8.0m)	13.4m	(6.3m)	(5.6m)	(4.6m)
% EBITDA margin	(157 %)	(113 %)	(114 %)	128 %	(89 %)	(68 %)	(49 %)
Profit	(13.0m)	(13.0m)	(11.0m)	(3.7m)	(9.0m)	(8.3m)	(7.5m)
% profit margin	(186 %)	(163 %)	(157 %)	(36 %)	(127 %)	(101 %)	(80 %)
EV / revenue	8.4x	6.3x	6.4x	4.3x	8.5x	8.4x	8.1x
EV / EBITDA	-5.3x	-5.6x	-5.6x	3.3x	-9.6x	-12.2x	-16.6x
R&D budget	3.2m	3.3m	4.1m	-	-	-	-
R&D % of revenue	46 %	41 %	58 %	-	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
Jan 2008	Seventure Partners Creadev Psilos Group	$30.0m	Series B
Jul 2011	N/A	N/A	IPO
Feb 2017*	IPF Partners	€7.0m	Debt
Dec 2019	N/A	$8.4m	Post IPO Equity
Apr 2020*	European Investment Bank	€6.0m	Post IPO Debt
May 2023*	Tasly Pharmaceutical	N/A	Post IPO Equity
Total Funding		€27.3m

Tech stackLearn more about the technologies and tools that this company uses.